Funding round brings in $6M for back pain drug developer

08/22/2013 | MedCityNews.com

Semnur Pharmaceuticals secured $6 million toward a funding round targeted at $30 million. The firm will use the proceeds to further develop its injectable drug for lower back pain. The drug is expected to enter midstage trials late next year.

View Full Article in:

MedCityNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY